As of 2025-07-03, the Relative Valuation of Nova Mentis Life Science Corp (NOVA.CN) is (1.67) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Nova Mentis Life Science Corp based on Relative Valuation is -4272.0%.
The range of the Relative Valuation is (1.58) - (1.70) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.9x - 37.5x | 33.7x |
| Forward P/E multiples | 34.9x - 45.1x | 40.0x |
| Fair Price | (1.58) - (1.70) | (1.67) |
| Upside | -4055.8% - -4341.1% | -4272.0% |
| Date | P/E |